ÍøºìºÚÁÏ

Allogeneic blood or marrow transplantation (alloBMT) is a curative therapy for a variety of hematologic disorders, including sickle cell disease and thalassemia. Even when it is clear that alloBMT can give to these patients an improvement in their…

Investigators

Jordan Milner, Biljana Horn

Status

Accepting Candidates

Ages

1 Year - 70 Years

Sexes

All

The investigators want to study if lower doses of chemotherapy will help babies with SCID to achieve good immunity with less short and long-term risks of complications after transplantation. This trial identifies babies with types of immune…

Investigators

Jordan Milner, Biljana Horn

Status

Accepting Candidates

Ages

0 Years - 2 Years

Sexes

All

This study will evaluate the use of non* TBI (total body irradiation) conditioning for B-ALL patients with low risk of relapse as defined by absence of NGS-MRD (next generation sequencing minimal residual disease) before receiving a hematopoietic…

Investigator

Jordan Milner

Status

Accepting Candidates

Ages

1 Year - 25 Years

Sexes

All